FDA

JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

by JDRF Bay Area 11.12.2010 Advocacy
Thumbnail image for JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.

Read the full article →

Qualitest Pharmaceuticals Issues a Voluntary Nationwide Recall of All Accusure® Insulin Syringes

by Greg Martin 10.30.2009 Press Releases

Share This press release was released by the company three days ago.  We hope you received the news faster than we received it here. FOR IMMEDIATE RELEASE – October 27, 2009 – Huntsville AL-Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes. The distributed syringes are of the following descriptions and [...]

Read the full article →

FDA Alert

by Greg Martin 08.14.2009 Press Releases

ShareAugust 14, 2009 The FDA has issued an alert about the possibility that people with type 1 diabetes who take certain medicines that contain non-glucose sugars might get falsely elevated readings from home blood sugar monitors if they use a specific kind of test strip.  These false high readings could be dangerous, because they might [...]

Read the full article →

Next Entries →